Correspondence 0001140361-25-010579 from Senti Biosciences, Inc. (SNTI) (CIK 0001854270) (SNTI)
Senti Biosciences, Inc. (SNTI) (CIK 0001854270)
Date: March 27, 2025 · CIK: 0001854270 · Accession: 0001140361-25-010579
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285983
Letter
Re:
Senti Biosciences, Inc. 2 Corporate Drive, First Floor South San Francisco, California 94080
March 27, 2025
VIA EDGAR
Securities and Exchange Commission Division of Corporation Finance – Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549
Senti Biosciences, Inc. Registration Statement on Form S-3 File No. 333-285983 Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Senti Biosciences, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-285983) (the “Registration Statement”), so that it may become effective at 8:00 am Eastern time on March 31, 2025, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
If you have any questions regarding this request, please contact Maggie Wong, Esq. of Goodwin Procter LLP at (415) 733-6071.
Very truly yours,
SENTI BIOSCIENCES, INC.
By:
Show Raw Text
CORRESP 1 filename1.htm Senti Biosciences, Inc. 2 Corporate Drive, First Floor South San Francisco, California 94080 March 27, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance – Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Senti Biosciences, Inc. Registration Statement on Form S-3 File No. 333-285983 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Senti Biosciences, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-285983) (the “Registration Statement”), so that it may become effective at 8:00 am Eastern time on March 31, 2025, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. If you have any questions regarding this request, please contact Maggie Wong, Esq. of Goodwin Procter LLP at (415) 733-6071. Very truly yours, SENTI BIOSCIENCES, INC. By: /s/ Timothy Lu Name: Timothy Lu Title: President & Chief Executive Officer Cc: Maggie Wong, Goodwin Procter LLP Jesse Fishman, Goodwin Procter LLP